Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Should Your Business Be Worried About Twitter Blue?

Twitters initial effort to charge money to verify accounts with a blue check mark is a mess, costing companies millions and damaging stock prices immensely. Videographer and Social Media Analyst Jordan Fussell highlights those companies most effected by such an influx in believable fake Twitter accounts. Jordan’s Thoughts: “Now, being a person who grew up…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Twitters initial effort to charge money to verify accounts with a blue check mark is a mess, costing companies millions and damaging stock prices immensely. Videographer and Social Media Analyst Jordan Fussell highlights those companies most effected by such an influx in believable fake Twitter accounts.

Jordan’s Thoughts:

“Now, being a person who grew up on the internet, one of the things that you’ll learn early on is that people love to pretend to be somebody else, like Michael Jackson or a prince who wants to send you his entire fortune if you’ll only send him about $500 in Target gift card, So the internet did what the internet do and proceeded to make multiple parody accounts, famous companies, and tweet out ridiculous things they would never say.

But by far, one of the most damaging was a parody account of the company, Eli Lilly, an American Pharmaceutical Company, who is responsible for a large production of insulin. And they tweeted out, “Exciting news! Insulin is now free for everyone,” and because of that verified check mark next to their name, proceeded this in the internet into a spiral.

Now the actual Eli Lilly Twitter account was able to do some damage control, but not before the company dropped. 10 points on Friday, which at the time of this recording, the company is still not recovered from. I believe the main takeaway from all of this is that Musk and Twitter need to crack down on a plan to not have somebody with $8 in a sense of humor, cost investors thousands of dollars for the push of a single button.”

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512